|
1. Hinkle JL, Kerry H, Cheever KH. Brunner and Suddarth's textbook of medical-surgical nursing. 13th ed. Philadelphia: Lippincott Williams & Wilkins. 2013; pp: 236-37. 2. Asadi Noughabi A, Shaban M, Faghihzadeh S, Asadi M. [Effect of cardiac rehabilitation program's first phase on anxiety in patients with coronary arteries bypass surgery]. Hayat. 2009; 14(3-4): 5-13. [Article in Persian] 3. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987 Jun;316(23):1429-35. doi:10.1056/NEJM198706043162301 4. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003 Apr; 348(14):1309-21. doi:10.1056/NEJMoa030207 5. David C. Currow, John Plummer, Peter Frith, and Amy P. Abernethy. J Palliat Med. 2007 Nov; 10(5): 1031-1036. https://doi.org/10.1089/jpm.2007.9912 6. Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2002 Feb;39(3):463-70. 7. Oxberry SG, Johnson MJ. Review of the evidence for the management of dyspnoea in people with chronic heart failure. Curr Opin Support Palliat Care. 2008 Jun;2(2):84-8. doi:10.1097/SPC.0b013e3282ff122e 8. Quill CM, Quill TE. Palliative use of noninvasive ventilation: navigating murky waters. J Palliat Med. 2014 Jun;17(6):657-61. doi:10.1089/jpm.2014.0010 9. Hadjiphilippou S, Odogwu S-E, Dand P. Doctors’ attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study. BMJ Support Palliat Care. 2014; 4(2):190-2. doi:10.1136/bmjspcare-2013-000565 10. Piotrowicz E, Stepnowska M, Leszczyńska-Iwanicka K, Piotrowska D, Kowalska M, Tylka J, et al. Quality of life in heart failure patients undergoing home-based telerehabilitation versus outpatient rehabilitation--a randomized controlled study. Eur J Cardiovasc Nurs. 2015 Jun;14(3):256-63. doi:10.1177/1474515114537023 11. Pantilat SZ, Steimle AE. Palliative care for patients with heart failure. JAMA. 2004 May; 291(20):2476-82. doi:10.1001/jama.291.20.2476 12. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005 Mar; 4(3):206-20. doi:10.1038/nrd1657 13. Yaghoobi K, Kaka GR, Davoodi Sh, Ashayeri H. [Therapeutic effects of Lavandula angustifolia]. J Gorgan Univ Med Sci. 2015; 17(4): 1-9. [Article in Persian] 14. Vafaei AA, Miladi-Gorgi H, Moghimi HR, Ameri M. [The effect of fruit Cassia fistula aqueous extract on sleeping time and the level of anxiety in mice]. J Gorgan Univ Med Sci. 2011; 12(4): 1-6. [Article in Persian] 15. Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Mol Med Rep. 2010 Nov; 3(6):895-901. doi:10.3892/mmr.2010.377 16. Singh O, Khanam Z, Misra N, Kumar Srivastava M. Chamomile (Matricaria chamomilla L.): An overview. Pharmacogn Rev. 2011; 5(9): 82–95. doi:10.4103/0973-7847.79103 17. Chang SM, Chen CH. Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. J Adv Nurs. 2016 Feb;72(2):306-15. doi:10.1111/jan.12836 18. Gould L, Reddy CV, Gomprecht RF. Cardiac effects of chamomile tea. J Clin Pharmacol. 1973 Nov-Dec;13(11):475-9. 19. McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006 Jul;20(7):519-30. doi:10.1002/ptr.1900 20. Cho MY, Min ES, Hur MH, Lee MS. Effects of aromatherapy on the anxiety, vital signs, and sleep quality of percutaneous coronary intervention patients in intensive care units. Evid Based Complement Alternat Med. 2013; 2013: 381381. doi:10.1155/2013/381381 21. Wilkinson S, Aldridge J, Salmon I, Cain E, Wilson B. An evaluation of aromatherapy massage in palliative care. Palliat Med. 1999 Sep; 13(5):409-17. doi:10.1191/026921699678148345 22. Chhabra SK, Gupta AK, Khuma MZ. Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease. Ann Thorac Med. 2009 Jul;4(3): 128-32. doi:10.4103/1817-1737.53351 23. Kaviani H, Mousavi AS. [Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI)]. Tehran Univ Med J. 2008; 66(2): 136-40. [Article in Persian] 24. Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J. 2010 Apr;31(7):832-41. doi:10.1093/eurheartj/ehp458 25. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009 Aug;29(4):378-82. doi:10.1097/JCP.0b013e3181ac935c 26. Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine. 2016 Dec; 23(14):1735-1742. doi:10.1016/j.phymed.2016.10.012
|
